Welcome to our dedicated page for Waters news (Ticker: WAT), a resource for investors and traders seeking the latest updates and insights on Waters stock.
Waters Corporation (NYSE: WAT) is a global leader in the field of analytical instruments and software solutions. For nearly six decades, the company has pioneered advancements in chromatography, mass spectrometry, and thermal analysis, catering to life, materials, and food sciences. Headquartered in Milford, Massachusetts, Waters Corp. operates directly in 35 countries, supported by approximately 8,000 employees and 15 manufacturing facilities globally.
Waters' main business segments include Waters, TA Instruments, VICAM, ERA, and Nonlinear Dynamics. The company's diverse product portfolio features ultra-performance liquid chromatography (UPLC), high-performance liquid chromatography (HPLC), chromatography columns, mass spectrometry systems, and laboratory informatics solutions. These innovations empower laboratory-dependent organizations to achieve advancements in healthcare, environmental management, food safety, and water quality.
Waters Corporation serves a wide array of customers, including biopharmaceutical companies (57% of sales), industrial clients (31% of sales), and academic/government institutions (12% of sales). The company’s products are available in over 100 countries, ensuring a broad market reach.
Recent achievements include the launch of new accessories for TA Instruments Discovery Hybrid Rheometers, designed for battery formulation analysis, and the introduction of Oasis WAX/GCB and GCB/WAX Cartridges for PFAS analysis. These innovations reflect the company’s commitment to addressing emerging scientific challenges and regulatory requirements. Additionally, Waters continues to enhance its mass spectrometry capabilities with products like the ACQUITY QDa II Mass Detector and the Xevo MRT MS, aimed at accelerating research in pharmaceuticals, food, chemicals, and materials.
Financially, Waters Corporation reported first-quarter 2024 sales of $637 million, with a strategic focus on innovation and operational efficiency. Despite a 7% decrease in sales compared to the previous year, the company remains optimistic about future growth, driven by new product launches and higher growth areas.
Waters Corporation stands as a pivotal player in the analytical instruments industry, consistently driving scientific advancements and operational excellence.
Waters Corporation (NYSE:WAT) plans to host a live webcast of its Q4 2020 financial results conference call on February 2, 2021, at 8:00 a.m. EST. Investors can access the call on Waters’ website. A replay will be available until February 9, 2021. Waters has been a pioneer in chromatography and mass spectrometry innovations for over 60 years, operating in 35 countries with more than 7,000 employees, contributing to sectors like life sciences and materials analysis.
Waters Corporation (NYSE:WAT) has announced that the Xevo TQ-XS atmospheric pressure gas chromatography mass spectrometry (APGC-MS/MS) platform has been approved by the USEPA for the identification of dioxins and furans in environmental samples. This approval follows a two-year collaboration with SGS AXYS Analytical Services, signifying a significant advancement in testing methods. The APGC-MS/MS method offers a more efficient, cost-effective, and sensitive alternative to traditional testing methods, which often involve complex and expensive instrumentation.
Waters Corporation (NYSE:WAT) announces that Udit Batra, Ph.D., CEO, will address investors at the J.P. Morgan Healthcare Conference on January 12, 2021, at 8:20 AM EST. The presentation will be accessible via live webcast through the company's investor relations webpage. As a premier specialty measurement company, Waters has over 60 years of experience in chromatography, mass spectrometry, and thermal analysis, operating in 35 countries with more than 7,000 employees globally.
Waters Corporation (NYSE:WAT) has appointed Dr. Pearl S. Huang, a distinguished executive with extensive scientific and pharmaceutical expertise, as a Director effective January 1, 2021. Dr. Huang currently leads Cygnal Therapeutics and has previously held significant roles at Roche and GSK, co-founding BeiGene. Waters' leadership emphasized that her experience will enhance the company’s growth in the pharma and biopharma sectors. This strategic addition to the board is expected to drive innovation and broaden the company's footprint in pharmaceutical and clinical laboratories globally.
Waters Corporation (NYSE:WAT) has enhanced its partnership with Dr. Sunghwan Kim from Kyungpook National University to advance the application of its ion mobility spectrometry (IMS) technology in analyzing complex chemical mixtures. This collaboration aims to improve the characterization of crude oil, potentially boosting efficiency and profitability in the petroleum sector, valued at over $3 billion daily. The innovative CYCLIC IMS instrument is expected to significantly enhance the analysis of crude oil components and support the development of advanced materials in electronics.
Waters Corporation (NYSE:WAT) announces the resignation of Chief Financial Officer Sherry Buck, effective December 31, 2020, to pursue a new opportunity. Michael F. Silveira, the Vice President and Corporate Controller, will take over as interim CFO, ensuring a smooth transition. The company is actively searching for a permanent CFO with several strong candidates identified. The management expresses confidence in the finance team's ability to continue the company's transformation and meet financial objectives, highlighting Silveira's extensive experience at Waters.
Waters Corporation (NYSE: WAT) reported third quarter 2020 sales of $594 million, a 3% increase from $577 million in Q3 2019, benefiting from foreign currency translation by about 1%. Diluted EPS fell to $2.03 on a GAAP basis, but rose to $2.16 on a non-GAAP basis. For the first nine months, sales totaled $1,579 million, a 7% decline from $1,690 million in 2019. Operating cash flow was up to $523 million. Q3 sales grew in pharmaceuticals and industrial markets but declined in academic/government sectors. CEO Udit Batra aims to enhance commercial execution and product development.
On October 26, 2020, Andrew Alliance, a Waters Company, received the 2020 North American Product Leadership Award from Frost & Sullivan for its innovative Andrew+ pipetting robot. This robot combines traditional pipettes with robotic mechanisms to enhance the reproducibility of liquid handling in labs. The cloud-based software, OneLab, facilitates remote access and customization of protocols. Andrew Alliance emphasizes product reliability and eco-friendliness, using carbon-neutral energy sources in manufacturing.
Waters Corporation (NYSE:WAT) announced the launch of its ACQUITY™ PREMIER Columns, featuring MaxPeak™ High Performance Surface (HPS) technology. These premium sub-2-micron columns significantly enhance data quality by reducing sample analyte loss due to adsorption. Designed for comprehensive use with UHPLC systems, these columns improve sample throughput and assay reproducibility, addressing a critical challenge in analytic laboratories. The product aims to bolster analytical confidence across various applications, including small molecules and biopharmaceuticals.
Waters Corporation (NYSE:WAT) will host a live webcast of its Q3 2020 financial results conference call on October 27 at 8:00 a.m. ET. Investors can access the call through Waters' website, with a replay available until November 3. Waters is a leader in specialty measurement technologies, focusing on chromatography, mass spectrometry, and thermal analysis across various sectors including life and materials sciences. The company operates in 35 countries with over 7,000 employees and has a significant global presence, featuring 15 manufacturing facilities.
FAQ
What is the current stock price of Waters (WAT)?
What is the market cap of Waters (WAT)?
What industries does Waters Corporation serve?
What are some of Waters Corporation's recent product launches?
How does Waters Corporation contribute to scientific advancements?
What is the significance of the TA Instruments Discovery Hybrid Rheometers?
How is Waters Corporation performing financially?
Where is Waters Corporation headquartered?
How many employees does Waters Corporation have?
What are TA Instruments' main products?
What is the significance of the Oasis WAX/GCB Cartridges?
How can I access Waters Corporation's financial results?
